In addition, we show that these CDK9 inhibitors reduced gene expression associated with differentiation state and stemness, which might affect cancer stem cell population, cell differentiation and/or cancer cell plasticity (e.g. proliferation/dormancy and epithelial-to-mesenchymal plasticity). This evidence concerns the gene CDK9 and cancer.